Costs and outcomes of mobile cardiac outpatient telemetry monitoring post-transcatheter aortic valve replacement
Publication: Journal of Comparative Effectiveness Research
Abstract
Aim: To estimate the costs and outcomes of transcatheter aortic valve replacement (TAVR) recipients based on the use of mobile cardiac outpatient telemetry (MCOT) monitoring. Materials & methods: A retrospective database study was conducted to estimate costs, contribution margins (CMs), pacemaker insertions and other outcomes for patients undergoing TAVR procedures with MCOT monitoring post-procedure versus non-MCOT monitoring. Results: A total of 4164 patients were identified (283 MCOT monitoring and 3881 non-MCOT monitoring). The rate of pacemaker insertion following hospital discharge was higher in the MCOT cohort (6.6 MCOT vs 2.1% non-MCOT; p = 0.007). MCOT use was associated with lower costs and improved CMs of the index TAVR admission (costs: US$40,569 MCOT vs $43,289 non-MCOT; p = 0.003; CMs: US$7087 MCOT vs $5177 non-MCOT; p = 0.047) with no difference through the subsequent 60-day period following discharge. Conclusion: MCOT for ambulatory cardiac monitoring post-TAVR discharge is associated with higher rates of pacemaker insertion, at no overall greater costs.
Supplementary Material
File (supplementary materials (7).docx)
- Download
- 17.62 KB
References
Papers of special note have been highlighted as: • of interest
1.
Kourkoveli K, Spargias K, Hahalis G. TAVR in 2017 – what we know? What to expect? J. Geriatr. Cardiol. 15(1), 55–60 (2018).
2.
Rotman OM, Bianchi M, Ghosh RP. Principles of TAVR valve design, modelling, and testing. Expert Rev. Med. Dev. 15(11), 771–791 (2018).
3.
Osnabrugge RLJ, Mylotte D, Head SJ et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. 62(11), 1002–1012 (2013).
4.
Arora S, Strassle PD, Kolte D et al. Length of stay and discharge disposition after transcatheter versus surgical aortic valve replacement in the United States. Circ. Cardiovasc. Interv. 11(9), e006929 (2018).
5.
Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597–1607 (2010).
6.
Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366(18), 1696–1704 (2012).
7.
Carroll JD, Mack MJ, Vemulapalli S et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 76(21), 2492–2516 (2020).
• Provides an overview of transcatheter aortic valve replacement patients, procedures, and outcomes from 2013–2019 from the Society of Thoracic Surgeons–American College of Cardiology TVT registry.
8.
American Academy of Cardiology. FDA expands TAVR indication to low-risk patients. (Accessed 10 January 2022) www.acc.org/latest-in-cardiology/articles/2019/08/16/13/49/fda-expands-tavr-indication-to-low-risk-patients
9.
Spears J, Al-Saiegh Y, Goldberg D et al. TAVR: a review of current practices and considerations in low-risk patients. J. Interv. Cardiol. 2020, 2582938 (2020).
10.
Rodés-Cabau J, Ellenbogen KA, Krahn AD et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel. J. Am. Coll. Cardiol. 74(8), 1086–1106 (2019).
• Multidisciplinary expert panel provides a guide for the management of conduction disturbances after transcatheter aortic valve replacement.
11.
Nazif TM, Dizon JM, Hahn RT et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc. Interv. 8(1 Pt A), 60–69 (2015).
12.
Mas-Peiro S, Fichtlscherer S, Walther C et al. Current issues in transcatheter aortic valve replacement. J. Thorac. Dis. 12(4), 1665–1680 (2020).
13.
Rodés-Cabau J, Urena M, Nombela-Franco L et al. Arrhythmic burden as determined by ambulatory continuous cardiac monitoring in patients with new-onset persistent left bundle branch block following transcatheter aortic valve replacement: the MARE study. JACC Cardiovasc. Interv. 11(15), 1495–1505 (2018).
14.
Ream K, Sandhu A, Valle J et al. Ambulatory rhythm monitoring to detect late high-grade atrioventricular block following transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 73(20), 2538–2547 (2019).
15.
Tian Y, Padmanabhan D, McLeod CJ et al. Utility of 30-day continuous ambulatory monitoring to identify patients with delayed occurrence of atrioventricular block after transcatheter aortic valve replacement. Circ. Cardiovasc. Interv. 12(12), e007635 (2019).
16.
Auffret V, Puri R, Urena M et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation 136(11), 1049–1069 (2017).
17.
Galli A, Ambrosini F, Lombardi F. Holter monitoring and loop recorders: from research to clinical practice. Arrhythm. Electrophysiol. Rev. 5(2), 136–143 (2016).
18.
Olson JA, Fouts AM, Padanilam BJ et al. Utility of mobile cardiac outpatient telemetry for the diagnosis of palpitations, presyncope, syncope, and the assessment of therapy efficacy. J. Cardiovasc. Electrophysiol. 18(5), 473–477 (2007).
19.
Derkac WM, Finkelmeier JR, Horgan DJ et al. Diagnostic yield of asymptomatic arrhythmias detected by mobile cardiac outpatient telemetry and autotrigger looping event cardiac monitors. J. Cardiovasc. Electrophysiol. 28(12), 1475–1478 (2017).
• Study demonstrates mobile cardiac outpatient telemetry devices are associated with faster intervention compared with other ambulatory monitoring options.
20.
Elixhauser A, Steiner C, Harris DR et al. Comorbidity measures for use with administrative data. Med. Care 36(1), 8–27 (1998).
21.
Centers for Medicare & Medicaid Services. Hospital 2552–2010 form. (Accessed 27 December 2021). www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/Cost-Reports/Hospital-2010-form
22.
Okoh AK, Chen C, Kassotis J et al. Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement. Catheter Cardiovasc. Interv. 99(4), 1243–1250 (2022).
Information & Authors
Information
Published In
Pages: 1045 - 1055
PubMed: 35899700
Copyright
© 2022 The Authors. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License
History
Received: 15 June 2022
Accepted: 15 July 2022
Published online: 28 July 2022
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Costs and outcomes of mobile cardiac outpatient telemetry monitoring post-transcatheter aortic valve replacement. (2022) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2022-0112
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Quentin Fischer, Isabelle Nault, Pedro Cepas-Guillén, Marisa Avvedimento, Carla Benavent-Garcia, Emilie Pelletier-Beaumont, François Philippon, Josep Rodés-Cabau, Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR, Circulation: Cardiovascular Interventions, 10.1161/CIRCINTERVENTIONS.125.016288, (2026).
- Jorge Nuche, Kenneth A. Ellenbogen, Suneet Mittal, Stephan Windecker, Carla Benavent, François Philippon, Josep Rodés-Cabau, Conduction Disturbances After Transcatheter Aortic Valve Replacement, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2024.07.032, 17, 22, (2575-2595), (2024).